Heart failure prevention for patients with type 2 diabetes
Official title: Evaluation of a Pragmatic NT-ProBNP-based Heart Failure Screening Strategy Among Patients With Type 2 Diabetes: STRONG-DM Study (Screening and Treatment Using Risk-based apprOach With NT-ProBNP Guidance in Diabetes Mellitus
Run by University of Texas Southwestern Medical Center · NCT06593327 · Data updated 2026-11-12
This study tests a new way to help people with type 2 diabetes avoid heart failure by using risk scores and alerts for their doctors to provide better care.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | University of Texas Southwestern Medical Center Academic / other |
| Locations | 3 sites (Dallas, Texas and 2 other locations) |
| Status | Recruiting |
| Started | February 10, 2025 |
| Main results expected | December 10, 2027 |
| Study ends | December 15, 2027 |
| Registry record updated | September 29, 2026 |
| Trial ID | NCT06593327 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are primary care providers who manage patients with type 2 diabetes.
✕Probably not a fit
Patients who do not have diabetes or those whose primary care providers do not participate in the study will not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial evaluates a heart failure risk assessment and prevention strategy for patients with type 2 diabetes using clinical risk scores and cardiac biomarkers. Primary care providers will receive notifications through electronic health records when their diabetic patients are identified as high risk for heart failure. The study aims to implement evidence-based preventive therapies and facilitate expert consultations or referrals to specialized programs. The goal is to enhance patient outcomes through proactive management of heart failure risks.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the incidence of heart failure in patients with type 2 diabetes.
How similar studies have gone: Other studies have shown promise in using similar risk assessment and prevention strategies, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Primary Care Provider that sees diabetes patients in clinic Exclusion Criteria: * Provider does not see patients with Diabetes
Where it's running
-
University of Texas Southwestern Medical Center
Dallas, Texas, United States Recruiting -
Parkland Health & Hospital System (PHHS)
Dallas, Texas, United States Recruiting -
Baylor Scott and White - Health System
Dallas, Texas, United States Recruiting
Study contacts
- Study coordinator: Ambarish Pandey, MD
- Email: ambarish.pandey@utsouthwestern.edu
- Phone: 617-869-8957
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Differentiating heart disease in autoimmune vs. type 2 diabetes
This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Global registry for patients with type 2 diabetes and related conditions
This study is collecting information from doctors around the world about patients with type 2 diabetes and related health issues to better understand how these conditions are managed and treated.
-
Acute Blood Flow Restriction Walking in Type 2 Diabetes
This study tests whether adding blood flow restriction to treadmill walking affects immune cells in adults with type 2 diabetes.
-
Continuous Glucose Monitoring in Type 2 Diabetes Not on Insulin
This study tests whether using a continuous glucose monitoring system helps people with type 2 diabetes who aren’t using insulin to improve blood sugar control and quality of life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.